Use of ribofuranose derivatives against inflammatory bowel...

Details Use of ribofuranose derivatives against inflammatory bowel... Use of ribofuranose derivatives against inflammatory bowel...

2005-08-16

2005-08-16

Wilson, James O. (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S021800, C514S235800, C514S026000, C514S378000, C514S008100, C530S350000, C536S028600, C536S028700, C536S028800, C536S023100, C536S023500, C544S224000, C546S252000, C546S255000, C546S300000

Reexamination Certificate

active

06930093

ABSTRACT:
A method for the prophylaxis or treatment of an inflammatory bowel disease is provided, comprising administering to a patient having or at risk of developing an inflammatory bowel disease a therapeutically or preventatively effective amount of one or more ribofuranose derivatives having the Formula (I):wherein R is a group selected from a carboxamide, an amidine, and pharmaceutically acceptable acid addition salts thereof, and the configuration at the C2carbon of the ribofuranose moiety is D or L. The one or more ribofuranose derivatives (I) may be used in combination with further active agents such as antivirals or agents effective against inflammatory bowel disease.

REFERENCES:
patent: RE29835 (1978-11-01), Witkowski et al.
patent: 5767097 (1998-06-01), Tam
patent: 5907036 (1999-05-01), Ramasamy et al.
patent: 6130326 (2000-10-01), Ramasamy et al.
patent: 6277836 (2001-08-01), Borody
patent: 6455508 (2002-09-01), Ramasamy et al.
patent: 6518253 (2003-02-01), Tam
patent: 6552183 (2003-04-01), Ramasamy et al.
patent: 6573248 (2003-06-01), Ramasamy et al.
patent: 6610665 (2003-08-01), Bays et al.
U. Ruther, et al., “Herpes-Simplex-Assozierte Exaserbation Eines Morbus Crohn,” Dtsch. Med. Wschr. 117 (1992), 46-50.
Pharamprojects. PJB Publications Ltd., Apr. 2003.
“Target Crohn's and Colitis,” Association of the British Pharmaceutical Industry, Feb. 2002.

Affiliated with

Also associated with

Rating

Use of ribofuranose derivatives against inflammatory bowel... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of ribofuranose derivatives against inflammatory bowel..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ribofuranose derivatives against inflammatory bowel... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3462881